Fig. 1From: An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trialDose escalation schemes in Group I and II. The maximal dose of 6000 TU was repeated after 14 and 28 days in both groupsBack to article page